Obstetrics, Gynecology and Reproduction

Advanced search

Current aspects of pathogenesis and prophylaxis of pelvic adhesions

Full Text:


Introduction. Adhesive process of the pelvic organs is a pressing issue for operative gynecology that does not allow to consider results of therapeutic and preventive measures as sufficient.

Aim: to analyze published data regarding contemporary aspects of etiopathogenesis of the adhesive process in pelvic organs as well as methods of its prevention.

Materials and Methods. The literature sources retrieved from electronic databases PubMed, Embase, Medline, Ovid HealthSTAR, Cochrane, Google Scholar, eLibrary, CyberLeninka as well as scientific articles published in peer-reviewed open access journals over the last 30 years, including basic research in the field have been analyzed. While searching, the following keywords and their combinations in Russian and English were used: "adhesive process of the pelvic organs", "pathogenesis of the adhesive process", "prevention of the adhesive process", "gynecology", "pelvic adhesions", "pathogenesis of adhesions", "аdhesion prophylaxis", "gynecology".

Results. The current aspects of the etiology and pathogenesis for adhesive process have been summarized. Existing adhesion classifications are presented. The proposed methods for preventing formation of peritoneal adhesions are described exerting most prominent effectiveness as well as describing the properties and characteristics according to the application method, the composition of contained substances and drug form. A phenotype profile of peripheral blood and peritoneal fluid lymphocytes from patients with adhesive process remains debated.

Conclusion. A need to further examine formation of peritoneal adhesions at molecular and cellular levels for developing a comprehensive pathogenetically substantiated method to prevent and treat adhesions of the pelvic organs is in demand.

About the Authors

G. A. Puchkina
Medical Academy named after S.I. Georgievsky, Crimean Federal University named after V.I. Vernadsky
Russian Federation

Galina A. Puchkina – Assistant, Department of Obstetrics, Gynecology and Perinatology № 1

5/7 Lenin Boulevard, Simferopol, Republic of Crimea 295006, Russia

A. N. Sulima
Medical Academy named after S.I. Georgievsky, Crimean Federal University named after V.I. Vernadsky
Russian Federation

Anna N. Sulima – MD, Dr Sci Med, Professor, Department of Obstetrics, Gynecology and Perinatology № 1

5/7 Lenin Boulevard, Simferopol, Republic of Crimea 295006, Russia


1. Binda M.M. Humidification during laparoscopic surgery: overview of the clinical benefits of using humidified gas during laparoscopic surgery. Arch Gynecol Obstet. 2015;292(5):955–71.

2. Coccolini F., Ansaloni L., Manfredi R. et al. Peritoneal adhesion index (PAI): proposal of a score for the «ignored iceberg» of medicine and surgery. World J Emerg Surg. 2013;8(1):6.

3. De Wilde R.L., Brölmann H., Koninckx P.R. et al. Prevention of adhesions in gynaecological surgery: the 2012 European field guideline. Gynecol Surg. 2012;9(4):365–8.

4. Haney A.F., Doty E. A barrier composed of chemically cross-linked hyaluronic acid (Incert) reduces postoperative adhesion formation. Fertil Steril. 1998;70(1):145–51.

5. Diamond M.P., DeCherney A.H., Linsky C.B. et al. Assessment of carboxymethylcellulose and 32% dextran 70 for prevention of adhesions in a rabbit uterine horn model. Int J Fertil. 1988;33(4):278–82.

6. DiZerega G.S. Peritoneum, peritoneal healing and adhesion formation. In: Peritoneal Surgery. New York: Springer-Verlag, 2000. 3–37. Available at: [Accessed: 27.10.2019].

7. Lutsevich O.E., Akimov V.P., Shirinsky V.G., Bichev A.A. Adhesive disease of the peritoneum: a modern view of pathogenesis and treatment. [Spaechnaya bolezn' bryushiny: sovremennyj vzglyad na patogenez i lechenie]. Hirurgiya. 2017;(10):100–8. (In Russ.).

8. Gómez-Gil V., García-Honduvilla N., Pascual G. et al. Peritoneal adhesion formation and reformation tracked by sequential laparoscopy: optimizing the time point for adhesiolysis. Surgery. 2010;147(3);378–91.

9. Herbali O.Yu., Butyrsky A.G. A method for prevention of intraperitoneal postoperative adhesions. [Sposob profilaktiki vnutribryushnyh posleoperacionnyh speak]. Patent RF № 2673380 ot 26.11.2018. Byul. № 33. 3 s. (In Russ.).

10. Cahill R.A., Wang J.H., Soohkai S., Redmond H.P. Mast cells facilitate local VEGF release as an early event in the pathogenesis of postoperative peritoneal adhesions. Surgery. 2006;140(1):108–12.

11. Bezhenar V.F., Niauri D.A., Selkov S.A. et al. Pathophysiological aspects of adhesion (analytic review). [Patofiziologicheskie aspekty. spajkoobrazovaniya (analiticheskij obzor)]. Klinicheskaya bol'nica. 2012;(4):86–94. (In Russ.).

12. Chegini N., Kotseos K., Zhao Y. et al; Peritoneal Healing and Adhesion Multiuniversity Study Group. Expression of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions. Fertil Steril. 2001;76(6):1212–9.

13. Kovacs E.J., DiPietro L.A. Fibrogenic cytokines and connective tissue production. FASEB J. 1994;8(11):854–61.

14. Zeyneloglu H.B., Senturk L.M., Seli E. et al. The role of monocyte chemotactic protein-1 in intraperitoneal adhesion formation. Hum Reprod. 1998;13(5):1194–9.

15. Kovacs E.J. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today. 1991;12(1):17–23.

16. Lazarenko V.A., Konoplya A.I., Lipatov V.A. et al. On the role of the immune system in the development of adhesions of the abdominal cavity (literature review). [K voprosu o roli immunnoj sistemy v razvitii spaechnogo processa bryushnoj polosti (obzor literatury)]. Nauchnyj elektronnyj zhurnal Innova. 2016;(4):29–33. (In Russ.).

17. Snimshchikova I.A., Medvedev A.I., Khalilov M.A. et al. Theoretical and clinical aspects of excessive adhesiogenesis. [Teoreticheskie i klinicheskie aspekty izbytochnogo adgeziogeneza]. Vestnik RGMU. 2008;(4):99–102. (In Russ.).

18. Oosterlynck D.J., Lacquet F.A., Waer M., Koninckx P.R. Lymphokinactivated killer activity in women with endometriosis. Gynecol Obstet Invest. 1994;37(3):185–90.

19. Rybalka A.N., Sulima A.N., Davydova A.A. et al. Features of proinflammatory cytokines expression in pelvic adhesions tissue at women with pelvic chronic inflammatory diseases. [Osobennosti ekspressii provospalitel'nyh citokinov v tkani tazovyh spaek u zhenshchin s hronicheskimi vospalitel'nymi zabolevaniyami organov malogo taza]. Juvenis Scientia. 2016;(3):29–31. (In Russ.).

20. Shmaneva I.A., Snimshchikova I.A., Antsupova V.S., Novikova E.P. The systemic cytokine therapy in the complex treatment of inflammatory diseases of pelvic organs. [Sistemnaya citokinoterapiya v kompleksnom lechenii vospalitel'nyh zabolevanij organov malogo taza]. Kurskij nauchno-prakticheskij vestnik «Chelovek i ego zdorov'e». 2008;(3):98–103. (In Russ.).

21. Dmowski P.W., Braun D.P. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):245–63.

22. Burlev V.A., Dubinskaia E.D., Gasparov A.S., Il'iasova N.A. Antiangiogenic therapy and a commissural process in the small pelvis: prospects for prevention and treatment. [Antiangiogennaya terapiya i spaechnyj process v malom tazu: perspektivy profilaktiki i lecheniya]. Rossijskij vestnik akushera-ginekologa. 2010;10(4):25–31. (In Russ.).

23. Kuyavskaya D.V., Grigoryan K.V., Torubarov S.F., Sukhikh G.T. Subpopulations of peripheral blood lymphocytes and peritoneal fluid in women with endometriosis. [Subpopulyacii limfocitov perifericheskoj krovi i peritoneal'noj zhidkosti u zhenshchin s endometriozom.] Problemy reprodukcii. 1999;(2):62–4. (In Russ.).

24. Dubinskaya E.D., Gasparov A.S., Burlev V.A. et al. Clinical markers of pelvic adhesion relapse. [Klinicheskie markery recidiva spaechnogo processa v malom tazu]. Vestnik RUDN. 2011;(6):186–92. (In Russ.).

25. Lysko A.I., Dudchenko A.M. Reperfusion injury and phenomenon "no reflow". Role of superoxide anion and peroxynitrite. [Reperfuzionnoe povrezhdenie i fenomen «no reflow», rol' superoksidnogo aniona i peroksinitrita]. Patogenez. 2014;12(4):47–51. (In Russ.).

26. Tabibian N., Swehli E., Boyd A. et al. Abdominal adhesions: A practical review of an often overlooked entity. Ann Med Surg (Lond). 2017;15:9–13.

27. Franzen C., Schlosser H., Beck L. Die mikrochirurgische Refertilisierung nach Tubensterilisation. Deutsches Ärzteblatt. 1979;18:2715–19.

28. The American Fertility Society classification of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril. 1988;49(6):944–55.

29. Hulka J. F., Reich H. Text book of laparoscopy. Philadelphia: W.B. Sounders, 1998. 548 р.

30. Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertil Steril. 1983;40(5):612–9.

31. The Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society of Reproductive Surgeons. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery: a committee opinion. Fertil Steril. 2013;99(6):1550–5.

32. Vorobiev A.A., Barinova E.A., Barinov A.S. et al. A method for evaluating adhesions. [Sposob ocenki spaechnogo processa]. Patent na izobretenie № 2202279 ot 23.05.2001. Byul. № 11. (In Russ.). Available at: [Accessed: 27.10.2019].

33. Coccolini F., Ansaloni L., Manfredi R. et al. Peritoneal adhesion index (PAI): proposal of a score for the "ignored iceberg" of medicine and surgery. World J Emerg Surg. 2013;8(1):6.

34. Ayushinova N.I., Shurygina I.A., Grigoryev E.G. The rating scale for the severity of abdominal adhesions. [Shkala ocenki stepeni vyrazhennosti spaechnogo processa bryushnoj polosti]. Acta Biomedical Scientifica. 2017;2(6):96–9. (In Russ.).

35. Bezhenar V.F., Ailamazian E.K., Bailiuk E.N. The etiology, pathogenesis and prevention of commissure formation during small pelvic surgery. [Etiologiya, patogenez i profilaktika spajkoobrazovaniya pri operaciyah na organah malogo taza]. Rossijskij vestnik akushera-ginekologa. 2011;11(2):90–101. (In Russ.).

36. Avsar F.M., Sahin M., Aksoy F. et al. Effects of diphenhydramine HCl and methylprednisolone in the prevention of abdominal adhesions. Am J Surg. 2001;181(6):512–5.

37. Lucas P.A., Warejcka D.J., Young H.E., Lee B.Y. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-beta1. J Surg Res. 1996;65(2):135–8.

38. Mahdy T., Mohamed G., Elhawary A. Effect of methylene blue on intraabdominal adhesion formation in rats. Int J Surg. 2008;6(6):452–5.

39. Berkkanoglu M., Zhang L., Ulukus M. et al. Inhibition of chemokines prevents intraperitoneal adhesions in mice. Hum Reprod. 2005;20(11):3047–52.

40. Replogle R.L., Johnson R., Gross Е.R. Prevention of postoperative intestinal adhesions with combined promethazine and dexamethasone therapy: experimental and clinical studies. Ann Surg. 1996;163(4):580–8.

41. Zemskova V.A., Korjakin A.V., Dorohina L.D. Multicomponent immunotherapy of inflammatory reproductive organs at women. [Mnogokomponentnaya immunoterapiya vospalitel'nyh zabolevanij reproduktivnyh organov u zhenshchin]. Vestnik novyh medicinskih tekhnologij. 2010;17(2):197–201. (In Russ.).

42. Shumsky V.I., Kaplin V.Yu., Gorenkov R.V. et al. Clinical experience of Derinat use – a new generation of immunomodulator. [Klinicheskij opyt ispol'zovaniya derinata – immunomodulyatora novogo pokoleniya]. Al'manah klinicheskoj mediciny. 1998;(1):433–44. (In Russ.).

43. Filenko B.P., Zemlyanoy V.P., Borsak I.I., Ivanov A.S. Adhesive disease: prevention and treatment. [Spaechnaya bolezn': profilaktika i lechenie]. SPb., 2013. 171 s. (In Russ.). Available at: [Accessed: 27.10.2019].

44. Ayushinova N.I., Shurygina I.A., Shurygin M.G., Glinskaya E.V. Assessment of adhesive process in abdominal cavity. [Ocenka vyrazhennosti spaechnogo processa v bryushnoj polosti]. Sibirskij medicinskij zhurnal (Irkutsk). 2014;130(7):10–4. (In Russ.).

45. Cipe G., Yildirim S., Köksal H. et al. Efficacy of hyaluronic acid – carboxymethyl cellulose membrane (Seprafilm®) and polylactic acid barrier film (Surgiwrap®) for the prevention of adhesions after thyroid surgery: an experimental model. Turk J Med Sci. 2011;41(1):73–9.

46. Strizheletsky V.V., Zhemchuzhina T.Yu., Axem S.M. et al. Intersid system as prophylaxisof the adhesions formation during gynecological surgery. [Ispol'zovanie sistemy intersid kak profilaktika obrazovaniya spaek pri ginekologicheskih operaciyah]. Zhurnal akusherstva i zhenskih boleznej. 2006;55(5):45. (In Russ.).

47. Bezhenar V.F., Tsypurdeeva A.A., Baylyuk E.N. Pelvic adhesive disease in gynecologic patients: from pathogenesis to prevention. [Spaechnaya bolezn' organov malogo taza u ginekologicheskih bol'nyh: ot patogeneza k profilaktike]. Onkoginekologiya. 2014;(4):68–74. (In Russ.).

48. The Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society of Reproductive Surgeons. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery: a committee opinion. Fertil Steril. 2013;99(6):1550–5.

49. Mettler L., Audebert A., Lehmann-Willenbrock E. et al. Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. J Am Assoc Gynecol Laparosc. 2003;10(3):339–44.

50. Fabiano G., Pezzolla A., Maiorino R., Ferrarese F. Peritoneal adhesions: pathophysiology. G Chir. 2008;29(3):115–25. (In Italian).

51. Sukovatykh B.S., Bezhin A.I., Lipatov V.A. et al. Clinical efficiency of intraabdominal implantation of antiadhesive agents "mesogel". [Klinicheskaya effektivnost' vnutribryushnoj implantacii protivospaechnogo sredstva «mezogel'»]. Vestnik novyh medicinskih tekhnologij. 2010;17(3):16–8. (In Russ.).

52. Kondratovich L.M. The basics for comprehension of adhesive process formation in abdominal cavity. Perioperative prevention by means of anti-adhesive drugs (review of literature). [Osnovy ponimaniya formirovaniya spaechnogo processa v bryushnoj polosti. Intraoperacionnaya profilaktika protivospaechnymi bar'ernymi preparatami]. Vestnik novyh medicinskih tekhnologij. 2014;21(3):169–73. (In Russ.).

53. Brochhausen C., Schmitt V., Planck C. et al. Current strategies and future perspectives for intraperitoneal adhesion prevention. J Gastrointest Surg. 2012;6:1256–74.

54. Ayushinova N.I., Shurygina I.A., Shurygin M.G., Panasuk A.I. Contemporary approaches to the prevention of intraperitoneal adhesions. [Sovremennye podhody k profilaktike spaechnogo processa v bryushnoj polosti]. Sibirskij medicinskij zhurnal (Irkutsk). 2011;105(6):16–20. (In Russ.).

55. Osada H., Tanaka H., Fujii T.K. et al. Clinical evaluation of a haemostatic and anti-adhesion preparation used to prevent post-surgical adhesion. J Int Med Res. 1999;27(5):247–52.

56. Konovodova E.N., Kan N.E., Kesova M.I., Kucherova O.N. Prospects for use of fibrin-collagen substance during abdominal surgery. [Perspektivy primeneniya fibrin-kollagenovoj substancii pri operativnyh vmeshatel'stvah na organah malogo taza]. Ginekologiya. 2012;14(3):64–9. (In Russ.).

For citation:

Puchkina G.A., Sulima A.N. Current aspects of pathogenesis and prophylaxis of pelvic adhesions. Obstetrics, Gynecology and Reproduction. 2020;14(4):523-533. (In Russ.)

Views: 58

ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)